Table 1.
Demographic statistics for each outcome.
| Demographics | Antibody response (n = 372) | Side effects (n = 460) | Affective outcomes (n = 462) |
|---|---|---|---|
| Age, mean (SD) | 52.06 (11.92) | 52.43 (11.89) | 52.41 (11.95) |
| Age, min - max | 18–76 | 18–76 | 18–76 |
| Sex, n (%) | |||
| Female | 242 (65.05%) | 294 (64.05%) | 295 (63.99%) |
| Male | 130 (34.95%) | 165 (35.95%) | 166 (36.01%) |
| Race and Ethnicity, n (%) | |||
| Asian | 99 (26.61%) | 116 (25.22%) | 116 (25.11%) |
| Black/African American | 8 (2.15%) | 15 (3.26%) | 15 (3.25%) |
| Hispanic/Latinx | 35 (9.41%) | 40 (8.70%) | 41 (8.87%) |
| White | 205 (55.11%) | 259 (56.30%) | 259 (56.06%) |
| Other/Multiracial/Unknown | 25 (6.72%) | 30 (6.52%) | 31 (6.71%) |
| Education, n (%) | |||
| Some college or less | 50 (13.44%) | 67 (14.57%) | 68 (14.72%) |
| 4-year degree | 151 (40.59%) | 181 (39.35%) | 181 (39.18%) |
| Professional degree/Doctorate | 171 (45.97%) | 212 (46.09%) | 213 (46.10%) |
Note: Sample size varies for each outcome measure. Sample size indicates total number in the sample in which age is calculated. Sample size also varies depending on availability of socio-demographic data. For example, for side effects, the total number of people who provided sex data was 459.